Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0000950170-23-046384

Options or other derivatives

  • Chief Financial Officer acquired 10,121,441 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Burrows Scott L · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +10,121,441 10,121,441 D
Loading xslF345X05/ownership.xml…